Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.
Porto biomedical journal(2020)
Abstract
Afzelin was predicted to inhibit TNBC cell motility, by targeting ERK2, KRas, and FAK activation.
MoreTranslated text
Key words
TNBC,afzelin,cell migration,reverse docking
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined